Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Inhibikase Therapeutics, Inc. IKT |
ARMISTICE CAPITAL LLC | 758,885 9.990% |
758,885 (New Position) |
Filing History |
| 2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | Gaxos.ai Inc. GXAI |
ARMISTICE CAPITAL LLC | 207,632 9.990% |
207,632 (New Position) |
Filing History |
| 2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | 5E Advanced Materials Inc. FEAM |
ARMISTICE CAPITAL LLC | 216,522 7.230% |
216,522 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Evaxion Biotech A/S EVAX |
ARMISTICE CAPITAL LLC | 111,055 9.990% |
111,055 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Enlivex Therapeutics Ltd. ENLV |
ARMISTICE CAPITAL LLC | 2,175,884 9.990% |
2,175,884 (New Position) |
Filing History |
| 2024-11-14 3:29 pm Purchase |
2024-09-30 | 13G | Ekso Bionics Holdings, Inc. EKSO |
ARMISTICE CAPITAL LLC | 2,192,713 9.990% |
1,794,021 (+449.98%) |
Filing History |
| 2024-11-14 3:28 pm Purchase |
2024-09-30 | 13G | Edible Garden AG Incorporated EDBL |
ARMISTICE CAPITAL LLC | 82,091 9.990% |
82,091 (New Position) |
Filing History |
| 2024-11-14 3:28 pm Purchase |
2024-09-30 | 13G | Danimer Scientific, Inc. DNMR |
ARMISTICE CAPITAL LLC | 12,018,677 9.900% |
12,018,677 (New Position) |
Filing History |
| 2024-11-14 3:27 pm Purchase |
2024-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF |
ARMISTICE CAPITAL LLC | 408,110 9.990% |
408,110 (New Position) |
Filing History |
| 2024-11-14 3:27 pm Purchase |
2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
ARMISTICE CAPITAL LLC | 222,655 9.990% |
222,655 (New Position) |
Filing History |
| 2024-11-14 3:26 pm Purchase |
2024-09-30 | 13G | Clene Inc. CLNN |
ARMISTICE CAPITAL LLC | 700,000 8.770% |
700,000 (New Position) |
Filing History |
| 2024-11-14 3:25 pm Purchase |
2024-09-30 | 13G | Banzai International, Inc. BNZI |
ARMISTICE CAPITAL LLC | 161,030 9.990% |
161,030 (New Position) |
Filing History |
| 2024-11-14 3:25 pm Purchase |
2024-09-30 | 13G | Bionomics Limited BNOX |
ARMISTICE CAPITAL LLC | 145,462 9.990% |
145,462 (New Position) |
Filing History |
| 2024-11-14 3:24 pm Purchase |
2024-09-30 | 13G | Brainstorm Cell Therapeutics Inc. BCLI |
ARMISTICE CAPITAL LLC | 8,083,946 9.990% |
8,083,946 (New Position) |
Filing History |
| 2024-11-14 3:24 pm Purchase |
2024-09-30 | 13G | Accelerate Diagnostics, Inc. AXDX |
ARMISTICE CAPITAL LLC | 2,400,000 9.930% |
2,400,000 (New Position) |
Filing History |
| 2024-11-14 3:23 pm Purchase |
2024-09-30 | 13G | Aspira Women's Health Inc. AWH |
ARMISTICE CAPITAL LLC | 1,256,000 7.760% |
1,256,000 (New Position) |
Filing History |
| 2024-11-14 3:23 pm Purchase |
2024-09-30 | 13G | Avinger, Inc. AVGR |
ARMISTICE CAPITAL LLC | 304,011 9.990% |
236,785 (+352.22%) |
Filing History |
| 2024-11-14 3:22 pm Purchase |
2024-09-30 | 13G | Avenue Therapeutics, Inc. ATXI |
ARMISTICE CAPITAL LLC | 115,000 7.210% |
115,000 (New Position) |
Filing History |
| 2024-11-14 3:22 pm Purchase |
2024-09-30 | 13G | Assembly Biosciences, Inc. ASMB |
ARMISTICE CAPITAL LLC | 354,000 5.580% |
354,000 (New Position) |
Filing History |
| 2024-11-14 3:22 pm Purchase |
2024-09-30 | 13G | Aptose Biosciences Inc. APTO |
ARMISTICE CAPITAL LLC | 65,173 9.990% |
65,173 (New Position) |
Filing History |